Review patient screening considerations and discuss how OUD screening can be integrated into current clinic workflows. Discuss the training and certifications required for specific team members to implement MOUD. Highlight the critical role of Champions, and how to strategically select Champions to support MOUD implementation.

Facilitator: Sherry Larkins, PhD, Director of International Programs and Research Sociologist, Integrated Substance Abuse Programs at the University of California, Los Angeles – Semel Institute for Neuroscience and Human Behavior

Cost: No fee

Target Audience: Physicians, nurse practitioners or other advanced practice nurses, PAs, psychologists, licensed counselors, social workers, clinical administrators, and healthcare teams.

Credit Designations Available: AMA PRA Category 1 Credit™, Nursing Contact Hours, AAPA Category 1 CME credit, and Interprofessional Continuing Education (IPCE) credit. Note: A Certificate of Attendance which acknowledges 1 hour of participation is also available (0 CE).

Webinar Description: Once your clinical site leadership has demonstrated an interest in exploring buprenorphine or other pharmacotherapies as a treatment option for opioid use disorder (OUD) patients, you must determine how to best assess organizational needs in a number of key areas including patient screening and identification, clinical capacity, workforce readiness and training, and more. How do you ensure the broader clinical workforce is properly trained and confident in their ability to identify and treat patients, and ensure access to a continuum of treatment and care services? This session will review clinic-wide implementation of new medications, and address ways to engage, identify and motivate site champions to work toward the implementation and integration of this clinical service. Finally, we will consider which metrics –immediate and long-term– are meaningful to your site, and how to gather relevant data to support reporting requirements, process improvement goals, and clinical decision-making in MOUD delivery.

Educational Objectives:

• Discuss site needs assessment to identify facilitators and barriers to medication for opioid use disorder (MOUD) implementation.
• Identify potential OUD patients, using evidence-based screening tools, and consider how screening can be integrated into current workflows.
• Review possible workflows, and the training and certifications required for specific team members to implement MOUD.
• Discuss treatment team members, the critical role of Champions, and how to strategically select Champions.
• Determine which metrics –immediate and long-term– are valuable to your site/program, and how you will gather relevant data. Consider how these metrics can be used to support federal/state reporting requirements, process improvement goals, and clinical decision-making in MOUD delivery.

Accreditation Statement:
In support of improving patient care, American Academy of Addiction Psychiatry is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE) and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.

Credit Designation Statements:

Physicians
American Academy of Addiction Psychiatry designates this live activity for a maximum of 1 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Nurses and Nurse Practitioners
American Academy of Addiction Psychiatry is an approved provider of nursing continuing education through AAAP’s Joint Accreditation provider #4008192. This activity is approved for up to 1 CNE credits.

PAs
American Academy of Addiction Psychiatry has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 1 AAPA Category 1 CME credits. PAs should only claim credit commensurate with the extent of their participation.

Other Health Professionals and Other Learners
Participants will receive a certificate stating this program is designated for 1 AMA PRA Category 1 Credits™. This credit is accepted by the AANP and the AAPA.

All Learners
This activity was planned by and for the healthcare team, and learners will receive 1 Interprofessional Continuing Education credits for learning and change.